Advanced Biomed Inc. Files 8-K for Material Agreement

Ticker: ADVB · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1941029

Advanced Biomed INC. 8-K Filing Summary
FieldDetail
CompanyAdvanced Biomed INC. (ADVB)
Form Type8-K
Filed DateMar 10, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, 8-k, regulatory-filing

TL;DR

ADVBI signs new material agreement, check 8-K for details.

AI Summary

Advanced Biomed Inc. filed an 8-K on March 10, 2025, reporting a material definitive agreement entered into on March 5, 2025. The filing also includes Regulation FD disclosures and financial statements/exhibits. The company is incorporated in Nevada and its principal executive offices are located in Tainan City, Taiwan.

Why It Matters

This filing indicates a significant new agreement for Advanced Biomed Inc., which could impact its business operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement?

The filing does not specify the details of the material definitive agreement, only that one was entered into on March 5, 2025.

When was this 8-K filing submitted?

The 8-K filing was submitted on March 10, 2025.

Where are Advanced Biomed Inc.'s principal executive offices located?

The principal executive offices are located at No. 689-85 Xiaodong Road, Yongkang District, Tainan City, Taiwan.

In which state is Advanced Biomed Inc. incorporated?

Advanced Biomed Inc. is incorporated in Nevada.

What are the key items reported in this 8-K?

The key items reported are the entry into a Material Definitive Agreement, Regulation FD Disclosure, and Financial Statements and Exhibits.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Advanced Biomed Inc. (ADVB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing